Efficacy and safety of anlotinib for patients with advanced NSCLC who progressed after standard regimens and the preliminary analysis of an efficacy predictor

JD Cheng, LX Chai, ZP Zhao, YY Hao… - Cancer management and …, 2020 - Taylor & Francis
Background The aim of this study was to investigate the efficacy and safety of anlotinib for
patients with advanced non-small cell lung cancer (NSCLC) who progressed after standard …
被引用次数：21 相关文章

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor.

JD Cheng, LX Chai, ZP Zhao, YY Hao… - Cancer Management and …, 2020 - europepmc.org
Background The aim of this study was to investigate the efficacy and safety of anlotinib for
patients with advanced non-small cell lung cancer (NSCLC) who progressed after standard …

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

JD Cheng, LX Chai, ZP Zhao… - Cancer management …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The aim of this study was to investigate the efficacy and safety of anlotinib for
patients with advanced non-small cell lung cancer (NSCLC) who progressed after standard …

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor.

JD Cheng, LX Chai, ZP Zhao, YY Hao… - Cancer Management and …, 2020 - go.gale.com
Background: The aim of this study was to investigate the efficacy and safety of anlotinib for
patients with advanced non-small cell lung cancer (NSCLC) who progressed after standard …
[HTML] nih.gov

[HTML][HTML] Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy …

JD Cheng, LX Chai, ZP Zhao, YY Hao… - Cancer Management and …, 2020 - ncbi.nlm.nih.gov
Background The aim of this study was to investigate the efficacy and safety of anlotinib for
patients with advanced non-small cell lung cancer (NSCLC) who progressed after standard …

Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy Predictor

JD Cheng, LX Chai, ZP Zhao, YY Hao… - Cancer Management and …, 2020 - dovepress.com
Background: The aim of this study was to investigate the efficacy and safety of anlotinib for
patients with advanced non-small cell lung cancer (NSCLC) who progressed after standard …
[PDF] semanticscholar.org

[PDF][PDF] Efficacy and Safety of Anlotinib for Patients with Advanced NSCLC Who Progressed After Standard Regimens and the Preliminary Analysis of an Efficacy …

JD Cheng, LX Chai, ZP Zhao… - Cancer Management …, 2020 - pdfs.semanticscholar.org
Background: The aim of this study was to investigate the efficacy and safety of anlotinib for
patients with advanced non-small cell lung cancer (NSCLC) who progressed after standard …